Zessly

Zessly (infliximab) is a biologic therapy used to treat inflammatory conditions like rheumatoid arthritis and Crohn’s disease. This intravenous medication helps reduce inflammation and manage symptoms. It is prescribed when other treatments have not been effective. Always follow healthcare provider guidance when using infliximab biosimilars.

Zessly (infliximab) is used to treat moderate to severe inflammatory diseases, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the immune system to reduce inflammation. Infliximab is typically used when other medications have not provided adequate relief. What is infliximab used for? It is prescribed for chronic inflammatory conditions that require immune system modulation.

Many patients experience reduced joint pain and swelling after starting Zessly (infliximab). It may take several weeks to notice improvements in symptoms. Some people report increased energy levels as inflammation decreases. Regular monitoring is important to assess how well the medication is working.

Keep all appointments for infusions, as Zessly (infliximab) is administered intravenously in a clinical setting. Inform your healthcare provider about any infections or recent illnesses before treatment. Avoid close contact with people who are sick while using this medication. Stay up to date on vaccinations as recommended by your doctor.

Zessly (infliximab) may interact with other immunosuppressants or live vaccines. Combining it with certain medications could increase infection risk. Alcohol use may worsen side effects like dizziness or nausea. Always review your current medications with your healthcare provider before starting infliximab.